Cargando…
The Actin Targeting Compound Chondramide Inhibits Breast Cancer Metastasis via Reduction of Cellular Contractility
BACKGROUND: A major player in the process of metastasis is the actin cytoskeleton as it forms key structures in both invasion mechanisms, mesenchymal and amoeboid migration. We tested the actin binding compound Chondramide as potential anti-metastatic agent. METHODS: In vivo, the effect of Chondrami...
Autores principales: | Menhofer, Magdalena H., Kubisch, Rebekka, Schreiner, Laura, Zorn, Matthias, Foerster, Florian, Mueller, Rolf, Raedler, Joachim O., Wagner, Ernst, Vollmar, Angelika M., Zahler, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229209/ https://www.ncbi.nlm.nih.gov/pubmed/25391145 http://dx.doi.org/10.1371/journal.pone.0112542 |
Ejemplares similares
-
Synthetic
Chondramide A Analogues Stabilize Filamentous
Actin and Block Invasion by Toxoplasma gondii
por: Ma, Christopher I., et al.
Publicado: (2013) -
Targeting actin inhibits repair of doxorubicin-induced DNA damage: a novel therapeutic approach for combination therapy
por: Pfitzer, Lisa, et al.
Publicado: (2019) -
Targeting the actin cytoskeleton: selective antitumor action via trapping PKCɛ
por: Foerster, F, et al.
Publicado: (2014) -
Turning the Actin Nucleating Compound Miuraenamide
into Nucleation Inhibitors
por: Wang, Shuaijun, et al.
Publicado: (2021) -
Persistent inhibition of pore-based cell migration by sub-toxic doses of miuraenamide, an actin filament stabilizer
por: Moser, Christina, et al.
Publicado: (2017)